Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Multicorp International, Inc. (OTC: MCIC).

Full DD Report for MCIC

You must become a subscriber to view this report.


Recent News from (OTC: MCIC)

MultiCorp International, Inc. Announces the Hiring of Healthcare Executive to Become New Chief Executive Officer
SUN VALLEY, CA--(Marketwired - Feb 11, 2016) - MultiCorp International, Inc, ( OTC PINK : MCIC ) announced today that the company has hired David Gustafson as the new CEO of the company. The company released the following statement, "MultiCorp International, Inc. is excited to announce t...
Source: Marketwired
Date: February, 11 2016 09:00
MultiCorp International, Inc. to Develop 4 Arm Study for Emergency Room Clinical Trials With Patented Migraine Medicine
SUN VALLEY, CA--(Marketwired - Jan 21, 2016) - MultiCorp International, Inc. ( OTC PINK : MCIC ) has received a report from the U.S. Food and Drug Administration that gives the company specific guidelines in creating a 4 arm study to administer the patented migraine medicine in an emergency...
Source: Marketwired
Date: January, 21 2016 09:00

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-08-170.0010.00110.00110.00091,010,930
2018-08-16N/A0.0007N/AN/A0
2018-08-15N/A0.0007N/AN/A0
2018-08-14N/A0.0007N/AN/A0
2018-08-13N/A0.0007N/AN/A0

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-08-17189,1751,010,93018.7130Cover
2018-08-10190,000190,00199.9995Short
2018-07-31107,558267,55840.1999Short
2018-07-261,300,0002,378,06554.6663Short
2018-07-241,200,0001,203,49099.7100Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on MCIC.


About Multicorp International, Inc. (OTC: MCIC)

Logo for Multicorp International, Inc. (OTC: MCIC)

MultiCorp International, Inc is committed itself to the further development of the patented migraine medicine the company owns a significant percentage of. The company has received information from the U.S. Food and Drug Administration that provides the company with a clear path to further the development of the drug to bring to market. The company is currently looking to partner with a pharmaceutical company that can assist the company in bringing the migraine medicine to market. For further information please contact them at info multicorpinternational.com

 

 

 

Current Management

  • David Gustafson / Interim CEO
  • Paul D. Lisenby / CEO
  • Ben Friedman / President
  • Paul D. Lisenby / Chairman

Current Share Structure

  • Market Cap: $1,392,887 - 03/09/2018
  • Authorized: 1,750,000,000 - 11/01/2015
  • Issue and Outstanding: 1,392,887,031 - 11/01/2015
  • Float: 533,784,228 - 11/01/2015

 


Recent Filings from (OTC: MCIC)

Quarterly Report - MCIC 3rd Quarter
Filing Type: Quarterly Report - MCIC 3rd QuarterFiling Source: OTC Markets
Filing Date: November, 08 2015
Quarterly Report - MCIC 2nd Quarter
Filing Type: Quarterly Report - MCIC 2nd QuarterFiling Source: OTC Markets
Filing Date: October, 20 2015

 

 


Daily Technical Chart for (OTC: MCIC)

Daily Technical Chart for (OTC: MCIC)


Stay tuned for daily updates and more on (OTC: MCIC)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (OTC: MCIC)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in MCIC is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. DD Report does not own any shares of MCIC and does not buy, sell, or trade any shares of MCIC. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: http://dd.report/disclaimer/